These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8950556)

  • 1. Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection.
    He Q; Edelman K; Arvilommi H; Mertsola J
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):793-8. PubMed ID: 8950556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
    Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
    Isacson J; Trollfors B; Taranger J; Lagergård T
    Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
    He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
    J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.
    Bergfors E; Trollfors B; Taranger J; Lagergård T; Sundh V; Zackrisson G
    Int J Infect Dis; 1999; 3(3):140-6. PubMed ID: 10460925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
    Zackrisson G; Taranger J; Trollfors B
    J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of pertactin IgG antibodies for the diagnosis of pertussis.
    Trollfors B; Lagergård T; Gunnarsson E; Taranger J
    Clin Microbiol Infect; 2003 Jul; 9(7):585-9. PubMed ID: 12925096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
    Gonik B; Puder KS; Gonik N; Kruger M
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin.
    Hussein AH; Davis EM; Halperin SA; Lee SF
    Infect Immun; 2007 Nov; 75(11):5476-82. PubMed ID: 17724067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis.
    Trollfors B; Zackrisson G; Taranger J; Lagergård T
    J Pediatr; 1992 Jun; 120(6):924-6. PubMed ID: 1593352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
    Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
    Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of antibodies to Bordetella antigens in German adults.
    Saemann-Ischenko G; Tillmanns B; Kösters K; Riffelmann M; Wirsing von König CH
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):850-3. PubMed ID: 11837635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.